Expiration of Royalty Term. On a region-by-region basis, upon the expiration of the Royalty Term for a given Product in a given region, the licenses granted by TPTX to Zai under Section 2.1 of this Agreement in such region with respect to such Product in the Field shall become fully paid-up, perpetual, irrevocable and sublicenseable in multiple tiers.

Expiration of the Term. In the event that the Term expires upon the completion of either # the Initial Term or # Extended Term (either (i) or (ii), a “Qualifying Expiration”), the Executive shall be deemed to become an at-will employee of the Company and the Employer as of such Qualifying Expiration. The terms of Section 1(b) (“Position and Duties”) shall apply to the Executive in his employment as an at-will employee; provided that from and after a Qualifying Expiration, the reference to the “Term” in Section 1(b) shall mean the period of the Executive’s at-will employment. In addition, Sections 7 to 21 of this Agreement shall continue to apply during and after such period of at-will employment in accordance with their terms. Any party may terminate such at-will employment by written notice with or without Cause and with or without advance notice. Effective immediately upon any Qualifying Expiration, the Executive shall participate in and be eligible to benefit from the severance plan, if any, that is then in effect and is generally applicable to senior executive officers of the Company and/or the Employer who do not have a written employment agreement with the Company and/or the Employer (an “Applicable Severance Plan”). For the avoidance of doubt, the Executive shall participate in and be eligible to benefit from any Applicable Severance Plan if a Qualifying Expiration occurs, regardless of whether any period of the Executive’s performance of services as an at-will employment follows such Qualifying Expiration, subject to the terms of such Applicable Severance Plan. Also for the avoidance of doubt, unless otherwise provided in an Applicable Severance Plan, a modification of the Executive’s compensation terms upon or after a Qualifying Expiration shall not be considered to constitute a termination of the Executive’s employment by the Company or the Employer unless such modification constitutes a constructive discharge.

Expiration of the Term. In the event that, due to the issuance of a Notice of Non-Renewal, the Term expires upon the completion of the Initial Term or the completion of a One-Year Period (either of which is a “Qualifying Expiration”), the Executive shall be deemed to become an at-will employee of the Company and the Employer as of such Qualifying Expiration, unless the Notice of Non-Renewal states that the Executive’s employment shall end effective upon the Qualifying Expiration. The terms of Section 1(b) (“Position and Duties”) shall apply to the Executive in his employment as an at-will employee; provided that from and after a Qualifying Expiration, the reference to the “Term” in Section 1(b) shall mean the period of the Executive’s at-will employment. In addition, Sections 6 to 22 of this Agreement shall continue to apply during and after such period of at-will employment in accordance with their terms. Any party may terminate such at-will employment by written notice with or without Cause and with or without advance notice. Effective immediately upon any Qualifying Expiration, the Executive shall participate in and be eligible to benefit from the severance plan, if any, that is then in effect and is generally applicable to senior executive officers of the Company and/or the Employer who do not have a written employment agreement with the Company and/or the Employer (an “Applicable Severance Plan”). For the avoidance of doubt, the Executive shall participate in and be eligible to benefit from any Applicable Severance Plan if a Qualifying Expiration occurs, regardless of whether any period of the Executive’s performance of services as an at-will employment follows such Qualifying Expiration, subject to the terms of such Applicable Severance Plan. Also for the avoidance of doubt, unless otherwise provided in an Applicable Severance Plan, a modification of the Executive’s compensation terms upon or after a Qualifying Expiration shall not be considered to constitute a termination of the Executive’s employment by the Company or the Employer unless such modification constitutes a constructive discharge.

If both # Executive’s employment has not been earlier terminated in accordance with Section 5, and # this Agreement has not been extended, renewed or replaced, then, upon the expiration of the Term, Executive’s employment will continue on an “at will” basis, such that either party may terminate employment at any time for any reason or no reason, any such termination shall not give rise to any notice, payment, severance or other obligations on the part of the Bank under this Section 6 or otherwise; or to any notice or other obligations on the part of Executive under this Section 6; or to any non-competition or non-solicitation restrictions under Section 12 hereof.

Term and Expiration. This Agreement shall be binding on the Parties as of the Effective Date. Thereafter, unless terminated earlier pursuant to Section 9.2 below, this Agreement shall extend for one (1) year which may expire on a country by country basis upon the earliest to occur of either # the expiration of the Kinex Patent Rights or # invalidation of the Kinex Patent Rights (the “Agreement Term”) unless either Party gives written notice of its intention not to extend the Agreement Term: # at least ninety (90) days prior to the expiration date of the Kinex Patent Rights; or # as soon as practically possible in the case of an invalidation claim; and # thereafter, at least ninety (90) days prior to the then current annual expiration date of the Agreement.

Term and Expiration. This Agreement shall commence on the Effective Date and, unless earlier terminated in accordance herewith, shall expire upon the expiration of the last-to-expire Royalty Term for the Licensed Products in the Territory and in any event no later than the 10th anniversary of the expiration of the last Valid Claim of an [[AstraZeneca:Organization]] Patent hereunder (such period, the “Term”). On a country-by-country basis, upon the expiration of a Royalty Term in a country, the license grants to Licensee under Section 2.1 (Grants to Licensee) will become fully paid-up, perpetual, and irrevocable for such country.

Term and Expiration. Subject to ARTICLE 2, this Agreement shall commence on the Effective Date and, unless earlier terminated in accordance herewith, shall continue in force and effect on a country-by-country basis until # in the case of the [[Address A:Address]], the later of # the one hundred twentieth (120th) day following the completion of any Calendar Quarter in which # neither Party nor any of its Affiliates or its or their sublicensees has conducted any Exploitation of a Licensed Compound or Licensed Product in the Licensed Field in the [[Address A:Address]], # neither Party nor any of its Affiliates or its or their sublicensees incurred any Reimbursable Development Expenses or Allowable US Expenses in connection with the Development, Commercialization or Exploitation of Licensed Compounds or Licensed Products in the Licensed Field in the [[Address A:Address]] and # there is no Development Plan or Commercialization Plan in effect, provided that clauses (A) and (C) both remain true on such one hundred twentieth (120th) day, and # the date on which there is no Royalty-Bearing Patent with respect to any Licensed Product in the [[Address A:Address]]; and # in the case of any country in the Royalty Territory, the date the Royalty Term for a Licensed Product for use in the Licensed Field has expired in such country (the “Term”).

Term and Expiration. This Agreement shall be effective as of the Effective Date and unless terminated earlier pursuant to [Section 8.2] below, this Agreement shall continue in effect until the expiration of the payment obligations of Dynavax pursuant to Article 4. Subject to [Section 8.28.2(b)], upon expiration of this Agreement, Dynavax’s license pursuant to Section 2.1 shall become fully paid-up, perpetual licenses.

Term and Expiration. The term during which an Option is exercisable shall be that period determined by the Administrator as set forth in the applicable Option Agreement, provided that no Option may be exercisable later than 10 years after the Date of Grant.

Agreement Term; Expiration. This Agreement is effective as of the Effective Date and, unless earlier terminated pursuant to the other provisions of this ARTICLE 9, will continue in full force and effect until the earliest to occur of # the Research Term Expiration Date or Research Term Mutual Termination, or # the date that the Joint Development and Commercialization Agreement becomes effective in accordance with [Section 4.1.2], and the consequences of such expiration are set forth in [Section 9.3.1] (and, for the avoidance of doubt, no other subsections of [Section 9.3] below).